𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tolerability of one hour 10mg/kg infliximab infusions in patients with inflammatory bowel disease

✍ Scribed by Babouri, Abdenour; Buisson, Anthony; Bigard, Marc-André; Peyrin-Biroulet, Laurent

Book ID
122096193
Publisher
Oxford University Press
Year
2013
Tongue
English
Weight
238 KB
Volume
7
Category
Article
ISSN
1873-9946

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Are accelerated infliximab infusions saf
Are accelerated infliximab infusions safe in patients with inflammatory bowel disease?
✍ Shivaram Bhat; Divyesh Sharma; Pauline Doherty; Tony C.K. Tham; Grant R. Caddy 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

Background: Infliximab is a monoclonal antibody used in the treatment of inflammatory bowel disease (IBD). The manufacturerrecommended administration is over 2 hours followed by 2 hours of patient observation. The data relating to adverse outcomes in patients receiving accelerated infusions for IBD